Company profile: StemoniX
1.1 - Company Overview
Company description
- Provider of stem cell–based, human-relevant in vitro platforms for drug discovery and toxicity testing. Products include NerveSim (3D peripheral nervous system model with nerve conduction and neurodegeneration metrics), BrainSim (3D brain organoid platform), and microBrain (human iPSC-derived CNS screening with functional cortical neuron–astrocyte networks). Founded in 2014, headquartered in Maple Grove, Minnesota.
Products and services
- BrainSim®: A 3D brain organoid platform replicating human brain structure and function, employed for neurotoxicity assessment and neurodegenerative disease research
- MicroBrain™: An iPSC-derived human CNS screening platform featuring cortical neurons and astrocytes forming functional networks, supporting CNS drug discovery and toxicity testing
- NerveSim®: A 3D in vitro peripheral nervous system model that delivers human-relevant data for drug discovery and toxicity testing, including nerve conduction measurements and neurodegeneration metrics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to StemoniX
Prism Pharma
HQ: United States
Website
- Description: Provider of cardiovascular injectable products for acute care, developing and commercializing therapies in the United States, including NEXTERONE, an antiarrhythmic injectable amiodarone, and PM103, an intravenous clopidogrel bisulfate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prism Pharma company profile →
Avalon GloboCare
HQ: United States
Website
- Description: Provider of precision diagnostics and clinical lab services—including bloodwork, anatomic pathology, urine/drug toxicology, STAT blood and genetic testing, pharmacogenomic (PGx) testing via real-time PCR, and PCR COVID-19 testing—delivered via its Lab Services MSO. Also offers the FDA Class I KetoAir Breathalyzer for ketosis detection and the QTY protein design platform (joint IP with MIT) for water-soluble cytokine receptor variants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avalon GloboCare company profile →
Prellis Bio
HQ: United States
Website
- Description: Provider of holographic two-photon bioprinting and the EXIS™ platform that recreates human immunobiology in vitro using 3D-printed lymph node organoids for antibody discovery, immunogenicity evaluation, and tumor immune systems; services include fully human antibody libraries, vaccine R&D, and large 3D tissue models for disease modeling, ADME/Tox, regenerative medicine, and transplantation into animal models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prellis Bio company profile →
Araris Biotech
HQ: Switzerland
Website
- Description: Provider of proprietary peptide linker technology for efficient payload attachment without antibody engineering, enabling creation of stable, homogenous, highly soluble antibody-drug conjugates (ADCs) with improved therapeutic efficacy and reduced side effects; also offers ADC development using off-the-shelf antibodies to deliver drugs to cancer cells with improved stability and solubility in a cost-effective manner.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Araris Biotech company profile →
Primerdesign
HQ: United Kingdom
Website
- Description: Provider of real-time PCR solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Primerdesign company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for StemoniX
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to StemoniX
2.2 - Growth funds investing in similar companies to StemoniX
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for StemoniX
4.2 - Public trading comparable groups for StemoniX
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →